Close Menu

NEW YORK – 10x Genomics reported after the close of the market on Tuesday a 49 percent increase in fourth quarter revenues driven by consumables sales.

For the three months ended Dec. 31, the Pleasanton, California-based single-cell analysis technologies firm reported $75.3 in revenues, up from $50.6 million during the prior-year period and beating the average Wall Street estimate of $70 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.